In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Johnson & Johnson partners with MD Anderson

Executive Summary

Johnson & Johnson signed a three-year agreement under which Johnson & Johnson Innovation LLC and Janssen Biotech Inc. will work with the University of TexasMD Anderson Cancer Center’s Moon Shots Program to develop immunology-based oncology therapeutics. The partners will work in undisclosed areas of interest to Janssen.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies